D-GL conjugate therapy
US4950469A · kind A · utility
7Cited by
5References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 7, 1988 |
| Grant date | Aug 21, 1990 |
| Priority date | — |
| Expiry date | Oct 7, 2008 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/868
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Receptor blocking technology using proteins conjugated to polymers of D-glutamic acid and D-lysine for treatment of antibody-mediated autoimmune disease, membrane and tumor disorders is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.